BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2026 9:45:12 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-04-01 03:37 |
|
Peer-Review Started |
|
2026-04-01 03:42 |
|
First Decision by Editorial Office Director |
|
2026-04-16 07:49 |
|
Return for Revision |
|
2026-04-16 08:08 |
|
Revised |
|
2026-04-20 17:05 |
|
Publication Fee Transferred |
|
2026-04-22 04:22 |
|
Second Decision by Editor |
|
2026-06-01 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-02 07:23 |
|
Articles in Press |
|
2026-06-02 07:23 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-21 09:25 |
|
Publish the Manuscript Online |
|
2026-09-09 09:45 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Chemotherapy regimens with immunotherapy in advanced gastric cancer: A prognostic study using Cox modeling
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shao-Wei Jiang, Chen-Guang Zhang, Ke-Di Wang, Kun-Peng Shang, Peng-Jie Yu and Huan-Li Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Qinghai Provincial Science and Technology Program |
No. 2023-ZJ-787 |
|
| Corresponding Author |
Huan-Li Wang, Professor, Qinghai University Affiliated Hospital Tumor Day Chemotherapy Center, Qinghai University Affiliated Hospital, No. 29 Tongren Road, Chengxi District, Xining 810000, Qinghai Province, China. 229572196@qq.com |
| Key Words |
Gastric cancer; Neoadjuvant therapy; Least absolute shrinkage and selection operator; Cox regression; Prognostic model |
| Core Tip |
This study compares three commonly used neoadjuvant regimens (S-1 combined with oxaliplatin and sintilimab, plus oxaliplatin and S-1, and oxaliplatin plus leucovorin and fluorouracil) in advanced gastric cancer and demonstrates that the addition of a programmed cell death protein 1 inhibitor improves pathological response without increasing unacceptable toxicity. Furthermore, a prognostic model integrating treatment response (Response Evaluation Criteria in Solid Tumors 1.1 and tumor regression grade) with clinicopathological factors provides reliable prediction of progression-free survival, highlighting the value of response-based variables in individualized risk stratification. |
| Publish Date |
2026-09-09 09:45 |
| Citation |
Jiang SW, Zhang CG, Wang KD, Shang KP, Yu PJ, Wang HL. Chemotherapy regimens with immunotherapy in advanced gastric cancer: A prognostic study using Cox modeling. World J Gastrointest Oncol 2026; 18(9): 121765
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i9/121765.htm |
| DOI |
https://doi.org/10.4251/wjgo.121765 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
